PROCEPT BioRobotics (PRCT) Change in Account Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Change in Account Payables data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 59.08% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 13.21% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 408.92% from the prior year.
• Change in Account Payables for Q1 2026 stood at $1.5 million, down from $5.9 million in the prior quarter.
• Over the last five years, Change in Account Payables for PRCT reached as high as $5.9 million in Q4 2025 and fell as low as -$5.4 million in Q4 2024.
• Historically, Change in Account Payables has averaged $928235.3 across 5 years, with a median of $448000.0 in 2022.
• Across the five-year window, Change in Account Payables surged 3722.22% in 2024 and plunged 754.07% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$284000.0 in 2022, then surged by 2169.01% to $5.9 million in 2023, then sank by 191.54% to -$5.4 million in 2024, then soared by 210.3% to $5.9 million in 2025, then slumped by 74.11% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $1.5 million in Q1 2026, $5.9 million in Q4 2025, and -$789000.0 in Q3 2025.